Glaxosmithkline Pharmaceuticals Ltd.

Financial

	Glaxosmithkline Phar	Glenmark Pharma	Ipca Laboratories
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	6.9 %	10.1 %	7.6 %
R&D as a % of Total Sales	0.07 %	6.6 %	2.64 %
Financials
5 yr Average ROE	32.25 %	4.18 %	14.77 %
5yr average Equity Multiplier	1.83	1.88	1.47
5yr Average Asset Turnover Ratio	0.96	0.79	0.79
5yr Avg Net Profit Margin	20.54 %	2.73 %	12.85 %
Price to Book	29.54	4.75	5.48
P/E	57.51	0.0	50.3
5yr Avg Cash Conversion Cycle	-70.08 Days	-121.67 Days	62.7 Days
Inventory Days	55.11 Days	40.44 Days	101.09 Days
Days Receivable	21.9 Days	36.38 Days	63.37 Days
Days Payable	130.75 Days	201.37 Days	112.44 Days
5yr Average Interest Coverage Ratio	297.48	3.48	55.69
5yr Avg ROCE	38.79 %	16.29 %	18.16 %
5yr Avg Operating Profit Margin	23.02 %	15.62 %	19.9 %
5 yr average Debt to Equity	0.0	0.49	0.16
5yr CAGR Net Profit	44.64 %	n/a	-2.03 %
5yr Average Return on Assets	17.78 %	1.86 %	10.46 %
Shareholdings
Promoter Holding	75.0 %	46.65 %	44.72 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-1.57 %
Change in Mutual Fund Holding (3 Yrs)	1.0 %	6.68 %	1.43 %

Business

	Glaxosmithkline Phar	Glenmark Pharma	Ipca Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 API 0 Generics 0 Branded Generics 0	Product Wise Break-Up Vaccines 0 API 0 Generics 0 Formulations 39.54 Branded Generics 60.46 Branded Generics 0 Pharmaceutical 0	Product Wise Break-Up Vaccines 0 Active Pharmaceutical Ingredient (API) 19.59 Formulations 31.07 Glenmark generics 0 Glenmark Pharma (Branded generics) 0 Branded Generics 49.34 Pharmaceutical 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	-	Therapeutic Area Wise Break-Up - Domestic Anti Malarials 3.0 Gastro Intestinal 2.0 Vaccines 0 Neutraceuticals 1.0 Cardiac Science 17.0 Pain Management 0 Anti-Infective 0 Cough and colds 4.0 Urology 4.0 Vitamins / Minerals / Nutrients 0 Central Nervous System (CNS) 3.0 Respiratory 0 Hormones 0 Dermatology 6.0 Pain 52.0 0 Anti-bacterial 6.0 Others 2.0
Location Wise Break-Up	Location Wise Break-Up India 98.22 Rest of the World 1.78 Europe 0 Latin America 0 North America 0 Asia (Excluding India) 0 Australia 0 CIS 0 USA 0 Africa 0	Location Wise Break-Up Rest of the World 22.11 North America 23.06 Africa 0 CIS 0 Asia (Excluding India) 0 USA 0 Australia 0 Europe 21.54 India 31.4 Latin America 0 Others 1.89	Location Wise Break-Up Rest of the World 0 North America 0 Africa 6.96 CIS 3.35 Asia Pacific 6.08 USA 17.83 Australia 4.05 Europe 15.39 India 46.34 Latin America 0
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

SIGN UP FOR FREE